Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer
1727.5000 44.90 (2.67%)
NSE Jul 15, 2025 15:31 PM
Volume: 3.3M
 

logo
Sun Pharmaceutical Industries Ltd.
30 May 2023
1727.50
2.67%
buy
by BOB Capital Markets Ltd.
Target: 1130
BOB Capital Markets Ltd.
Q4 revenue in line but adj. PAT 9% above consensus at Rs 21.8bn (+46% YoY) on account of strong margins
 
Number of FII/FPI investors increased from 1310 to 1351 in Mar 2025 qtr.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Five stocks to buy from analysts this week - July 15, 2025
The Baseline | 15 Jul 2025, 06:44PM
Market closes higher, ICICI Prudential's Q1 net profit surges 34.2% YoY to Rs 301 crore
Trendlyne Marketwatch | 15 Jul 2025, 03:56PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022